Rainer Becker
Director · EU
Meetings on record (latest 20 of 68)
- 2026-09-08 · AstraZeneca PLC · Exchange on the Biotech Act and other legislative files
- 2026-09-08 · Centrient Pharmaceuticals International B.V. · Exchange on the Critical Medicines Act
- 2026-07-29 · Irish Farmers' Association · Exchange of views on the EU legislation as regards the application of the prohibition of use of certain antimicrobial medicinal products in animals or products of animal origin exported from third countries into the Union
- 2026-07-29 · WuXi AppTec Europe GmbH · Courtesy meeting
- 2026-07-08 · QYOBO GmbH · Presentation of QYOBO’s supply chain platform
- 2026-07-02 · Invest Europe · Access to finance for Biotech companies and the Biotech Act
- 2026-06-30 · Merck Sharp & Dohme Europe Belgium SRL · Discussion on DG SANTE’s health policy agenda, the new Biotech act and the new pharmaceutical legislation
- 2026-06-02 · Pharmaceutical Group of the European Union · Availability of medicines, role of pharmacists, pharma package implementation
- 2026-05-21 · Verband Forschender Arzneimittelhersteller e.V. · Meeting of the vfa Expert Group on European Policy
- 2026-05-19 · Standing Committee of European Doctors · Exchange of views on the Biotech Act
- 2026-05-12 · European Federation of Pharmaceutical Industries and Associations · Exchange of views on work in IHI
- 2026-05-05 · Merck · EU pharmaceutical policy and competitiveness
- 2026-04-27 · Roland Berger GmbH · Exchange on the security of supply and resilience of pharmaceutical supply chains
- 2026-04-27 · Roland Berger GmbH · Exchange on the security of supply and resilience of pharmaceutical supply chains
- 2026-04-09 · European Business Summit NETWORK · Revision of the MDR, interplay with AI Act
- 2026-04-01 · Bristol-Myers Squibb Company · Exchange of views on the Biotech Act and on the international pharmaceutical situation
- 2026-03-30 · Association Internationale de la Mutualité · Presentation of AIM’s priorities in the area of pharmaceuticals and fair pricing work
- 2026-03-26 · Teva Pharmaceuticals Europe BV · Urban Waste Water Treatment Directive (UWWTD) and its impact on the generic pharmaceutical industry
- 2026-03-25 · CSL · Exchange of views on plasma-derived products, the Critical Medicines Act and biotech
- 2026-03-23 · Genmab A/S · Discuss the newly released Health Package, companion diagnostics under the ongoing review of the IVDR, the coherence between the Artificial Intelligence (AI) Act and sector-specific health legislation, the Biotech Act
Source: published meeting logs. Listing a meeting does not imply any wrongdoing.